Brief Summary

Septic pathology is an extremely frequent reason for consultation in our emergency services, with an annual incidence of severe forms between 50 to 95 cases per 100,000 inhabitants and a constant increase estimated at 9% per year. Diagnosing these patients early and precisely is a major challenge for the clinician, as this diagnosis will lead to more or less aggressive medical management. The criteria of S.I.R.S, used to define and to sort patients in sepsis according to the old definition, were completely abandoned in the last recommendations for lack of specificity but also of sensitivity. The latest recommendations suggest using another score, the "Quick Sepsis Related Organ Failure Assesment (qSOFA) score", in order to early detect septic patients at risk of poor progress. However, the recent literature highlights a very low sensitivity of the qSOFA score for the screening of septic patients, ranging from 30 to 60% according to the studies. In addition to qSOFA, other scores are described in the literature with apparently higher sensitivity, and thus seem more suitable for our daily practice. Among them is the NEWS score or the RETTS score. Each of these scores is again based upon the values of vital signs recorded as soon as the patient arrives in the emergency department. To date, very few studies have been interested, in a prospective way, in the sensitivity and the specificity of these different scores to diagnose the "infected" patients in the emergency departments. Therefore a non-interventional, prospective, multicenter cohort study is carried out here, in order to be able to compare, on the same cohort of patients admitted into emergency services, the diagnostic performance of these different scores with respect to the presence or absence of an infection. The aim of this study is to define the best clinical score to use in emergency medicine to quickly diagnose the infected patients, and offer them the best medical care.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
759

participants targeted

Target at P75+ for all trials

Timeline
Completed

Started Apr 2018

Shorter than P25 for all trials

Geographic Reach
1 country

7 active sites

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

April 9, 2018

Completed
4 days until next milestone

Primary Completion

Last participant's last visit for primary outcome

April 13, 2018

Completed
6 days until next milestone

First Submitted

Initial submission to the registry

April 19, 2018

Completed
5 months until next milestone

Study Completion

Last participant's last visit for all outcomes

September 1, 2018

Completed
2 months until next milestone

First Posted

Study publicly available on registry

October 17, 2018

Completed
Last Updated

October 17, 2018

Status Verified

October 1, 2018

Enrollment Period

4 days

First QC Date

April 19, 2018

Last Update Submit

October 12, 2018

Conditions

Keywords

EDERqSOFASOFARETTSNEWSSIRStriage

Outcome Measures

Primary Outcomes (5)

  • Initial vital signs upon arrival at ED triage to evaluate the qSOFA score

    * Respiratory rate (movements per minute) * Systolic blood pressure (Hg mm) * Glasgow coma score (number from 0 to 15) will be assessed to evaluate the qSOFA score (number from 0 to 3)

    Timepoint 0 (ED triage)

  • Initial vital signs upon arrival at ED triage to evaluate the NEWS score

    * Respiratory rate (movements per minute) * Pulsed SpO2 (%) with oxygen therapy (if applicable) and without oxygen therapy * Oxygen therapy (yes ou no) * Tympanic temperature (°C) * Systolic blood pressure (Hg mm) * Heart rate (beats per minute) * Glasgow coma score (number from 0 to 15) will be assessed to evaluate the NEWS score (number from 0 to 20)

    Timepoint 0 (ED triage)

  • Initial vital signs upon arrival at ED triage to evaluate the RETTS score

    * Blocked airway or stridor (yes or no) * Respiratory rate (movements per minute) * Pulsed SpO2 (%) without oxygen therapy * Heart rate (beats per minute) * Level of conciousness (alert, accute disorientation, somnolence, Glasgow\<9) * Tympanic temperature (°C) will be assessed to evaluate the RETTS score (4 classes from "green" to "red")

    Timepoint 0 (ED triage)

  • Initial vital signs upon arrival at ED triage and blood count to evaluate the SIRS score

    * Tympanic temperature (°C) * Heart rate (beats per minute) * Respiratory rate (movements per minute) * Leucocytemia (cells per mm³) will be assessed to evaluate the SIRS score (number from 0 to 4)

    Timepoint 0 (ED triage) and timepoint of blood sampling upon medical examination (average of 30 minutes after Timepoint 0)

  • Antibiotic therapy instauration by the physician either during the emergency care managment or when leaving the emergency department (antibiotic therapy mentionned in the exit prescrition)

    The prescription of an antibiotic therapy will define the presence of an infection

    from patient arrival in the ED, to his leaving (from 1 hour to 24 hours)

Secondary Outcomes (2)

  • Presence of a SOFA score value of 2 or greater

    from patient arrival in the ED, to his leaving (from 1 hour to 24 hours)

  • Overall survival at Day 28

    Day 1 to Day 28 (from patient arrival in the ED, to the 28th day after)

Interventions

Simple data collection from regular vital signs recordings during the initial phase of care management in the emergency department. Missing data is then possibly completed by the physician when made available during the regular medical management of the patient.

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)
Sampling MethodNon-Probability Sample
Study Population

-Patients meeting the eligibility criteria from all participating investigational centers during the study period

You may qualify if:

  • Patient of 18 years old or more
  • Patients consulting in the emergency department
  • Verbal agrement to participate

You may not qualify if:

  • Patients consulting for an isolated traumatologic reason
  • Patients under legal protection

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (7)

Centre Hospitalier d'Antibes

Antibes, Alpes Maritimes, 06600, France

Location

Centre Hospitalier de Grasse

Grasse, Alpes Maritimes, 06130, France

Location

Centre Hospitalier Universitaire de Nice

Nice, Alpes Maritimes, 06001, France

Location

Hôpital de la Timone

Marseille, Bouches Du Rhône, 13005, France

Location

Hôpital Nord

Marseille, Bouches Du Rhône, 13005, France

Location

Hôpital Saint Anne

Toulon, Var, 83000, France

Location

Hôpital Sainte Musse

Toulon, Var, 83000, France

Location

MeSH Terms

Conditions

SepsisShock, SepticInfectionsEmergenciesDisease

Condition Hierarchy (Ancestors)

Systemic Inflammatory Response SyndromeInflammationPathologic ProcessesPathological Conditions, Signs and SymptomsShockDisease Attributes

Study Design

Study Type
observational
Observational Model
COHORT
Time Perspective
PROSPECTIVE
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

April 19, 2018

First Posted

October 17, 2018

Study Start

April 9, 2018

Primary Completion

April 13, 2018

Study Completion

September 1, 2018

Last Updated

October 17, 2018

Record last verified: 2018-10

Data Sharing

IPD Sharing
Will not share

Locations